Completed OBSERVATIONAL NCT04146493

Heparin-Binding Protein and Heparins (HepHep)

Heparin-binding Protein and Heparins

Sponsor: Halla Halldorsdottir

Conditions Cardiovascular Diseases Thromboprophylaxis Vascular Disease, Peripheral

Interventions Blood samples for Heparin-binding protein measurement

Updated 8 times since 2019 Last updated: Nov 15, 2023 Started: Apr 1, 2019 Primary completion: Nov 30, 2021 Completion: Nov 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cardiovascular Diseases and Thromboprophylaxis, this trial is completed. The trial is conducted by Halla Halldorsdottir and has accumulated 8 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2023 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Dec 2021 — Dec 2023 [monthly]

Unknown Status
Nov 2021 — Dec 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jan 2021 — Nov 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Nov 2019 — Nov 2020 [monthly]

Recruiting

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Halla Halldorsdottir
Karolinska Institutet

Data source: Karolinska University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden